Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

Background Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients. Methods A multicenter, single-arm, hypothesis-driven trial was planned, according to a phase 2 design, to study the effect of...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of translational medicine Vol. 18; no. 1; pp. 405 - 11
Main Authors:	Perrone, Francesco, Piccirillo, Maria Carmela, Ascierto, Paolo Antonio, Salvarani, Carlo, Parrella, Roberto, Marata, Anna Maria, Popoli, Patrizia, Ferraris, Laurenzia, Marrocco-Trischitta, Massimiliano M., Ripamonti, Diego, Binda, Francesca, Bonfanti, Paolo, Squillace, Nicola, Castelli, Francesco, Muiesan, Maria Lorenza, Lichtner, Miriam, Calzetti, Carlo, Salerno, Nicola Duccio, Atripaldi, Luigi, Cascella, Marco, Costantini, Massimo, Dolci, Giovanni, Facciolongo, Nicola Cosimo, Fraganza, Fiorentino, Massari, Marco, Montesarchio, Vincenzo, Mussini, Cristina, Negri, Emanuele Alberto, Botti, Gerardo, Cardone, Claudia, Gargiulo, Piera, Gravina, Adriano, Schettino, Clorinda, Arenare, Laura, Chiodini, Paolo, Gallo, Ciro
Format:	Journal Article
Language:	English
Published:	London BioMed Central 21.10.2020 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Adult Aged Aged, 80 and over Antibodies, Monoclonal, Humanized - therapeutic use Betacoronavirus - drug effects Betacoronavirus - immunology Biomedical and Life Sciences Biomedicine Care and treatment Clinical trials Cohort Studies Combination strategies Consent Coronavirus Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronaviruses COVID-19 Cytokines Drug dosages Female Humans Hypotheses IL-6 Immunosuppressive agents Inflammation Interleukin 6 Interleukins Italy - epidemiology Lethality Male Medicine/Public Health Middle Aged Monoclonal antibodies Mortality Off-Label Use Pandemics Phase 2 Pneumonia Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Population Registration SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Statistical analysis Steroid hormones Survival Tocilizumab Toxicity Treatment Outcome Validation Studies as Topic Variables Ventilation Italy COVID-19 Pneumonia Coronavirus Tocilizumab Mortality Phase 2 Safety IL-6
ISSN:	1479-5876, 1479-5876
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!